内科理论与实践

内科理论与实践 >

2021 , Vol. 16 >Issue 03: 155 - 160

DOI: https://doi.org/10.16138/j.1673-6087.2021.03.004

专家论坛

血管内超声指导冠状动脉左主干介入治疗

展开
  • 中国医学科学院阜外医院内分泌与心血管代谢中心,北京 100037

收稿日期: 2021-05-16

  网络出版日期: 2022-07-26

收起

本文引用格式

钱杰 . 血管内超声指导冠状动脉左主干介入治疗[J]. 内科理论与实践, 2021 , 16(03) : 155 -160 . DOI: 10.16138/j.1673-6087.2021.03.004

参考文献

[1] Giannoglou GD, Antoniadis AP, Chatzizisis YS, et al. Prevalence of narrowing >or=50% of the left main coronary artery among 17,300 patients having coronary angiography[J]. Am J Cardiol, 2006, 98(9): 1202-1205.
[2] Taylor HA, Deumite NJ, Chaitman BR, et al. Asymptomatic left main coronary artery disease in the Coronary Artery Surgery Study (CASS) registry[J]. Circulation, 1989, 79(6): 1171-1179.
[3] Mohr FW, Morice MC, Kappetein AP, et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial[J]. Lancet, 2013, 381(9867): 629-638.
[4] Stone GW, Sabik JF, Serruys PW, et al. Everolimus-eluting stents or bypass surgery for left main coronary artery disease[J]. N Engl J Med, 2016, 375(23): 2223-2235.
[5] Lindstaedt M, Spiecker M, Perings C, et al. How good are experienced interventional cardiologists at predicting the functional significance of intermediate or equivocal left main coronary artery stenoses?[J]. Int J Cardiol, 2007, 120(2): 254-261.
[6] Abizaid AS, Mintz GS, Abizaid A, et al. One-year follow-up after intravascular ultrasound assessment of moderate left main coronary artery disease in patients with ambiguous angiograms[J]. J Am Coll Cardiol, 1999, 34(3): 707-715.
[7] Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS guidelines on myocardial revascularization[J]. Eur Heart J, 2019, 40(2): 87-165.
[8] Zimmermann FM, Ferrara A, Johnson NP, et al. Deferral vs. performance of percutaneous coronary intervention of functionally non-significant coronary stenosis: 15-year follow-up of the DEFER trial[J]. Eur Heart J, 2015, 36(45): 3182-3188.
[9] Tonino PA, De Bruyne B, Pijls NH, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention[J]. N Engl J Med, 2009, 360(3): 213-224.
[10] de Bruyne B, Pijls NH, Kalesan B, et al. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease[J]. N Engl J Med, 2012, 367(11): 991-1001.
[11] Hamilos M, Muller O, Cuisset T, et al. Long-term clinical outcome after fractional flow reserve-guided treatment in patients with angiographically equivocal left main coronary artery stenosis[J]. Circulation, 2009, 120(15): 1505-1512.
[12] Jasti V, Ivan E, Yalamanchili V, et al. Correlations between fractional flow reserve and intravascular ultrasound in patients with an ambiguous left main coronary artery stenosis[J]. Circulation, 2004, 110(18): 2831-2836.
[13] de la Torre Hernandez JM, Hernández Hernandez F, Alfonso F, et al. Prospective application of pre-defined intravascular ultrasound criteria for assessment of intermediate left main coronary artery lesions results from the multicenter LITRO study[J]. J Am Coll Cardiol, 2011, 58(4): 351-358.
[14] Kang SJ, Lee JY, Ahn JM, et al. Intravascular ultrasound-derived predictors for fractional flow reserve in intermediate left main disease[J]. JACC Cardiovasc Interv, 2011, 4(11): 1168-1174.
[15] Park SJ, Ahn JM, Kang SJ, et al. Intravascular ultrasound-derived minimal lumen area criteria for functionally significant left main coronary artery stenosis[J]. JACC Cardiovasc Interv, 2014, 7(8): 868-874.
[16] Modi BN, van de Hoef TP, Piek JJ, et al. Physiological assessment of left main coronary artery disease[J]. EuroIntervention, 2017, 13(7): 820-827.
[17] Nascimento BR, de Sousa MR, Koo BK, et al. Diagnostic accuracy of intravascular ultrasound-derived minimal lumen area compared with fractional flow reserve-meta-analysis: pooled accuracy of IVUS luminal area versus FFR[J]. Catheter Cardiovasc Interv, 2014, 84(3): 377-385.
[18] Johnson TW, Räber L, di Mario C, et al. Clinical use of intracoronary imaging. Part 2: acute coronary syndromes, ambiguous coronary angiography findings, and guiding interventional decision-making: an expert consensus document of the European Association of Percutaneous Cardiovascular Interventions[J]. Eur Heart J, 2019, 40(31): 2566-2584.
[19] Oviedo C, Maehara A, Mintz GS, et al. Is accurate intravascular ultrasound evaluation of the left circumflex ostium from a left anterior descending to left main pullback possible[J]?. Am J Cardiol, 2010, 105(7): 948-954.
[20] Oviedo C, Maehara A, Mintz GS, et al. Intravascular ultrasound classification of plaque distribution in left main coronary artery bifurcations: where is the plaque really located[J]?. Circ Cardiovasc Interv, 2010, 3(2): 105-112.
[21] Kang SJ, Ahn JM, Kim WJ, et al. Functional and morphological assessment of side branch after left main coronary artery bifurcation stenting with cross-over technique[J]. Catheter Cardiovasc Interv, 2014, 83(4): 545-552.
[22] Sato K, Naganuma T, Costopoulos C, et al. Calcification analysis by intravascular ultrasound to define a predictor of left circumflex narrowing after cross-over stenting for unprotected left main bifurcation lesions[J]. Cardiovasc Revasc Med, 2014, 15(2): 80-85.
[23] Barbato E, Carrié D, Dardas P, et al. European expert consensus on rotational atherectomy[J]. EuroIntervention, 2015, 11(1): 30-36.
[24] Kang SJ, Ahn JM, Song H, et al. Comprehensive intravascular ultrasound assessment of stent area and its impact on restenosis and adverse cardiac events in 403 patients with unprotected left main disease[J]. Circ Cardiovasc Interv, 2011, 4(6): 562-569.
[25] Sonoda S, Morino Y, Ako J, et al. Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the sirius trial[J]. J Am Coll Cardiol, 2004, 43(11): 1959-1963.
[27] Song HG, Kang SJ, Ahn JM, et al. Intravascular ultrasound assessment of optimal stent area to prevent in-stent restenosis after zotarolimus-, everolimus-, and sirolimus-eluting stent implantation[J]. Catheter Cardiovasc Interv, 2014, 83(6): 873-878.
[28] Räber L, Mintz GS, Koskinas KC, et al. Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions[J]. Eur Heart J, 2018, 39(35): 3281-3300.
[29] Liu J, Maehara A, Mintz GS, et al. An integrated TAXUS Ⅳ, Ⅴ, and Ⅵ intravascular ultrasound analysis of the predictors of edge restenosis after bare metal or paclitaxel-eluting stents[J]. Am J Cardiol, 2009, 103(4): 501-601.
[30] Maehara A, Mintz GS, Stone GW. IVUS guidance during left main PCI: not if, but when and how[J]. EuroIntervention, 2020, 16(3): 189-191.
[31] de la Torre Hernandez JM, Garcia Camarero T, Baz Alonso JA, et al. Outcomes of predefined optimisation criteria for intravascular ultrasound guidance of left main stenting[J]. EuroIntervention, 2020, 16(3): 210-217.
[32] Ladwiniec A, Walsh SJ, Holm NR, et al. Intravascular ultrasound to guide left main stem intervention: a NOBLE trial substudy[J]. EuroIntervention, 2020, 16(3): 201-209.
[33] Tan Q, Wang Q, Liu D, et al. Intravascular ultrasound-guided unprotected left main coronary artery stenting in the elderly[J]. Saudi Med J, 2015, 36(5): 549-553.
[34] Park SJ, Kim YH, Park DW, et al. Impact of intravascular ultrasound guidance on long-term mortality in stenting for unprotected left main coronary artery stenosis[J]. Circ Cardiovasc Interv, 2009, 2(3): 167-177.
[35] Ye Y, Yang M, Zhang S, et al. Percutaneous coronary intervention in left main coronary artery disease with or without intravascular ultrasound[J]. PLoS One, 2017, 12(6): e0179756.
[36] de la Torre Hernandez JM, Baz Alonso JA, Gómez Hospital JA, et al. Clinical impact of intravascular ultrasound guidance in drug-eluting stent implantation for unprotected left main coronary disease: pooled analysis at the patient-level of 4 registries[J]. JACC Cardiovasc Interv, 2014, 7(3): 244-254.
[37] Kinnaird T, Johnson T, Anderson R, et al. Intravascular imaging and 12-month mortality after unprotected left main stem PCI[J]. JACC Cardiovasc Interv, 2020, 13(3): 346-357.
[38] Xu B, Redfors B, Yang Y, et al. Impact of operator experience and volume on outcomes after left main coronary artery percutaneous coronary intervention[J]. JACC Cardiovasc Interv, 2016, 9(20): 2086-2093.
[39] Liu XM, Yang ZM, Liu XK, et al. Intravascular ultrasound-guided drug-eluting stent implantation for patients with unprotected left main coronary artery lesions[J]. Anatol J Cardiol, 2019, 21(2): 83-90.
[40] Inaba S, Weisz G, Kobayashi N, et al. Prevalence and anatomical features of acute longitudinal stent deformation: an intravascular ultrasound study[J]. Catheter Cardiovasc Interv, 2014, 84(3): 388-396.
[41] Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions[J]. Catheter Cardiovasc Interv, 2012, 79(3): 453-495.
[42] 中华医学会心血管病学分会介入心脏病学组, 中国医师协会心血管内科医师分会血栓防治专业委员会, 中华心血管病杂志编辑委员会. 中国经皮冠状动脉介入治疗指南(2016)[J]. 中华心血管病杂志, 2016, 44(5): 382-400.
[43] Ge Z, Kan J, Gao XF, et al. Comparison of intravascular ultrasound-guided with angiography-guided double kissing crush stenting for patients with complex coronary bifurcation lesions: Rationale and design of a prospective, randomized, and multicenter DKCRUSH Ⅷ trial[J]. Am Heart J, 2021, 234: 101-110.
Options
文章导航

/

〈 〉